Document Detail

Novel paediatric anticoagulants: a review of the current literature.
MedLine Citation:
PMID:  20135753     Owner:  NLM     Status:  MEDLINE    
There are many limitations with respect to anticoagulants currently used in standard paediatric practice for prophylaxis and treatment of thrombosis: heparin, low molecular-weight heparin, and warfarin. Factors such as pharmacokinetic and dosing variability are further exacerbated by properties of the immature haemostatic system of children. These shortcomings necessitate exploring alternative anticoagulants in the paediatric population. In this review, we discuss several promising direct thrombin inhibitors and factor Xa inhibitors, and synthesize relevant drug information and clinical experience from the limited available case reports, case series, and nonrandomized dose-finding trials published to date.
Veronica H T Chan; Paul Monagle; Patti Massicotte; Anthony K C Chan
Related Documents :
21278393 - Septic arthritis following anterior cruciate ligament reconstruction secondary to clost...
15364633 - Thinking the unthinkable:the clinician as perpetrator of elder abuse in patients in pain.
4023883 - Superior dislocation of the hip. a report of 2 cases.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis     Volume:  21     ISSN:  1473-5733     ISO Abbreviation:  Blood Coagul. Fibrinolysis     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-02-04     Completed Date:  2010-04-20     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9102551     Medline TA:  Blood Coagul Fibrinolysis     Country:  England    
Other Details:
Languages:  eng     Pagination:  144-51     Citation Subset:  IM    
Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anticoagulants / therapeutic use*
Clinical Trials as Topic
Factor Xa / antagonists & inhibitors*
Thrombin / antagonists & inhibitors*
Reg. No./Substance:
0/Anticoagulants; EC; EC Xa

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Might platelet-leucocyte complexes be playing a role in major vascular involvement of Beh??et's dise...
Next Document:  Making them pay. High-cost of healthcare reform is fueling more fraud enforcement, putting hospitals...